Cardiovascular Function and Treatment in Beta-Thalassemia Major
Published: June 17, 2013

- Heart failure (HF) is the most common cause of death in Thalassemia Major.
- In patients with Beta-thalassemia Major, acute and chronic forms of heart failure require different treatment.
- Life expectancy is extended with use of chelation therapy.